Strategy Asset Managers LLC Has $1.06 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Strategy Asset Managers LLC raised its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 165.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,242 shares of the company's stock after acquiring an additional 6,388 shares during the period. Strategy Asset Managers LLC's holdings in Colgate-Palmolive were worth $1,063,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. E Fund Management Hong Kong Co. Ltd. acquired a new stake in Colgate-Palmolive in the second quarter valued at about $25,000. Continuum Advisory LLC lifted its holdings in shares of Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock worth $38,000 after acquiring an additional 125 shares during the period. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $42,000. Capital Performance Advisors LLP purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter worth about $53,000. Finally, Prospera Private Wealth LLC purchased a new position in shares of Colgate-Palmolive in the 3rd quarter valued at $64,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Shares of NYSE CL traded up $0.42 during trading on Wednesday, hitting $94.03. The company had a trading volume of 1,667,590 shares, compared to its average volume of 4,378,579. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The company has a market cap of $76.82 billion, a P/E ratio of 26.90, a PEG ratio of 3.34 and a beta of 0.42. The business's 50-day moving average is $98.80 and its 200 day moving average is $98.56. Colgate-Palmolive has a 52 week low of $75.39 and a 52 week high of $109.30.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date was Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.13%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on CL shares. Morgan Stanley upped their target price on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an "overweight" rating in a research note on Monday, July 29th. Sanford C. Bernstein lifted their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a "market perform" rating in a research report on Tuesday, July 30th. HSBC reissued a "hold" rating on shares of Colgate-Palmolive in a report on Friday, July 26th. UBS Group lifted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a "buy" rating in a report on Wednesday, September 4th. Finally, StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research note on Thursday, November 14th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $105.11.

Insider Activity

In related news, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. This trade represents a 16.44 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.